Algo version: 0.98b
Biocon Limited is listed at the NSE Exchange
Biocon Limited [BIOCON.NS]
NSE Sector: Healthcare Industry:Biotechnology

Is Biocon Limited stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Biocon Limited pays dividends. Last time was Friday 23rd of August 2024 where the investors holding the stock on Friday 5th of July 2024 were paid INR0.5 per share. Over the last 20 times between 2004 and 2024, Biocon Limited has paid INR52 with an average of INR2.6 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Biocon Limited 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR233.45, you would have made a profit of INR140.25 per share or 60.08%

Yes, the average daily trading liquidity for Biocon Limited is INR5.14 million. You should therefore be able to get in and out of your positions relatively fast.

Biocon Limited has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.15, the company's ability to pay off the debt is normal. Biocon Limited has a good net profit margin of 7.13% and should have high tolerances against inflation.

We have calculated the inflation risk for Biocon Limited to be low [0.4 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.